Dymicron

Early Stage

Replace.Restore.Revitalize

Overview

Platform

Dealmaker Securities

Start Date

01/24/2023

Close Date

01/24/2024

Min. Goal

$1,001

Max. Goal

$15,824,560

Min. Investment

$1,001

Security Type

Equity - Common

Series

Series B

Funding Type

RegA+

Price Per Share

$5.75

Pre-Money Valuation

$28,820,535

Location

Orem, Utah

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

Dymicron is raising funds through Reg A+ crowdfunding with Dealmaker Securities as the Broker-Dealer. It is a medical device technology company making a new generation of musculoskeletal devices. The company uses its patented material, Polycrystalline Diamond, for its devices that can be used in all interbody applications. Dymicron’s first product, the Triadyme-C, is a cervical total disc replacement device made of PCD and able to replicate natural spinal motion. Alan S. Layton founded Dymicron in 1997. The current crowdfunding campaign has a maximum target of $15.8 million. The campaign proceeds will be used for clinical trials, FDA applications, commercialization of Triadyme-C in Europe, research and development, and general and administrative expenses.

Balance Sheet

Cash and Cash Equivalents

$1,202,541

Accounts and Notes Receivable

$40,741

Property, Plant and Equipment (PP&E)

$385,028

Total Assets

$2,488,964

Accounts Payable & Accrued Liabilities

$238,391

Long Term Debt

$45,730,124

Total Liabilities

$68,586,613

Total Stockholders' Equity

$-66,097,649

Total Liabilities and Equity

$2,488,964

Statement of Comprehensive Income Information

Total Revenues

$104,292

Costs & Expenses Applicable to Rev

$49,831

Depreciation and Amortization

$37,236

Net Income

$-4,084,223

Earnings Per Share - Basic

$-0.09

Earnings Per Share - Diluted

$-0.09

Financials as of: 01/24/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Analyst Report Analyst Report Methodology Article

Pending Review

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Dymicron on Dealmaker Securities 2023
$
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $28,820,535

Follow company

Follow Dymicron on Dealmaker Securities 2023
View on Dealmaker Securities